Therapeutic and cosmetic applications of mangiferin: A patent review

Expert Opinion on Therapeutic Patents

Volumn 23, Issue 12, 2013, Pages 1561-1580

  Telang, Manasi ^a   Dhulap, Sivakami ^a   Mandhare, Anita ^a   Hirwani, Rajkumar ^a  

^a CSIR Unit for Research and Development of Information Products   (India)

Author keywords

Anticancer; Antiinfectious; Antiinflammatory; Antioxidant; Cosmeceutical; Mangiferin; Mangiferin derivative; Metabolic disorder

Indexed keywords

COSMETIC; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGIFERIN;

ABSENCE OF SIDE EFFECTS; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; AUTOIMMUNE DISEASE; DRUG BIOAVAILABILITY; DRUG DATABASE; DRUG POTENCY; DRUG STRUCTURE; HUMAN; INFECTION; INFLAMMATION; METABOLIC DISORDER; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; PATENT; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTIOXIDANTS; COSMETICS; DRUG DESIGN; FREE RADICAL SCAVENGERS; HUMANS; MANGIFERA; PATENTS AS TOPIC; SIGNAL TRANSDUCTION; XANTHONES;

EID: 84890066155     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2013.836182     Document Type: Review

References (89)

1. Masibo M, He Q. In vitro antimicrobial activity and the major polyphenol in leaf extract of Mangifera indica L. Malays J Microbiol 2009;5(2):73-80
2. Wauthoz N, Balde A, Balde ES, et al. Ethnopharmacology of Mangifera indica L. Bark and pharmacological studies of its main C-glucosylxanthone, mangiferin. Int J Biomed Pharm Sci 2007;1(2):112-19
3. Matkowski A, Kuśś P, Góralska E, et al. Mangiferin-A bioactive xanthonoid, not only from mango and not just antioxidant. Mini Rev Med Chem 2013;13(3):439-55
4. Dimitrov M, Nikolova I, Benbasat N, et al. Acute toxicity, antidepressive and mao inhibitory activity of mangiferin isolated from Hypericum aucheri. Biotechnol Biotechnol Eq 2011;25(4):2668-71
5. Vyas A, Syeda K, Ahmad A, et al. Perspectives on medicinal properties of mangiferin. Mini Rev Med Chem 2012;12(5):412-25
6. Univ Tianjin Traditional Chinese Medicin. Diffractive-ring mangiferin A in mango leaves and new application of mango leaf extractives containing diffractive-ring mangiferin A. CN101693034B; 2010
7. Univ No 2 Military Medical Pla, Guangzhou Laitai Pharm Co., Ltd. Rhizoma anemarrhenae extract and preparation process and use thereof. CN1434053A; 2003
8. Hainan Deze Drug Res Co., Ltd. Teng H, Wu W, Xu GA. Novel Mangiferin Calcium Salts, the Method For Its Preparation And Its Use. WO2009065287A1; 2009
9. Hainan Deze Drug Res Co., Ltd. Xu GA. Novel Mangiferin Calcium Salts, The Method For Its Preparation And Its Use. WO2008061480A1; 2008
10. Nanjing University. Mango Aglycone, Preparation Purification Process And Uses Thereof. CN101367787A; 2009
11. Shanghai Changzheng Hospital. Mangiferin aglycon derivative and preparation method and use thereof. WO2012116629A1; 2012
12. Tianjin University Of Traditional Chinese Medicine. Wang T, Zhang Y, Liu E, et al. Foliamangiferosides, Preparation Method And Use Thereof. WO2011044751A1; 2011
13. No.2 Army Medical College, P.L.A. Glycoside Class Compound of Mango, Preparation Method, and Application in Area of Medicine. CN101003558A; 2007
14. Sky International Kk and Sakurai Keizo. Intrahepatic Gluconeogenesis Inhibitor and Food or Food Formulation Ingredient. JP2007176915A; 2007
15. Sky International Kk and Sakurai Keizo. Gluconeogenesis Inhibitor in Liver and Food or Food Additive Containing the Same. JP2007204462A; 2007
16. Nanjing Univ. Medicine for Treating Diabete type-2 And Its Estimation Model. CN100998601A; 2007
17. Xu GA. Drug Composition For Treating 2 type Diabetes And Its Chronicity Neopathy. WO2008043246A1; 2008
18. Kunming Pharmaceutical Corp. Mangiferin Aglycon Medicinal Complex and Preparation Method and Applications Thereof. CN102351888A; 2012
19. Kunming Medical College and Kunming Pharmaceutical Corp. New Use of Mangiferin Compounds. CN101214254B; 2008
20. Kunming Pharmaceutical Group Co., Ltd. Composition with Blood Uric Acid Adjusting Function. CN102652761A; 2012
21. Southwest University. Medicine of 3-Alkoxyl-Mangiferin for Lowering Blood Pressure, Synthesis and Application. CN101648948B; 2010
22. Mentzer C, Ratsimamanga Albert R. Improvements In and Relating To Therapeutic Compositions Containing Mangiferin. GB1099764A; 1968
23. Haofu D. Mangiferin compound or mango extract used as pancreatic lipase inhibitor preparation method of preventing and treating obesity of the medicine or food application of. CN102920696A; 2013
24. Tianjin Inst Pharm Research. Tibetan Capillaris Extract and Preparation Method, Pharmaceutical Composition and Use Thereof. CN102138966B; 2011
25. Qinghai Pulante Pharmaceutical. Capillary Artemisia Dripping Pill and Its Prepn Process. CN1846726A; 2006
26. Northwest Institute Of Plateau Biology, Chinese Academy Of Sciences, Donger Pharmaceutical Co., Ltd. Tibetan Capillary Extract And Preparation Method, Medicine Composition And Use Thereof. CN101396428B; 2009
27. Shengwugu Science And Technolo. Medicine Qingyedan for Curing Hepatitis And Its Preparing Method. CN1391928A; 2003
28. Lab Biologie Vegetale Rocher Yves. Glycosylation of mangiferine by biocatalyst, useful in cosmetic field to protect skin comprises contacting mangiferine with a glycosyltransferase enzyme, in the presence of a sugar donor. FR2882762B1; 2006
29. Rocher Yves Biolog Vegetale. Cosmetic Use of Mangiferin. US2006088560A1; 2006
30. Rocher Yves Biolog Vegetale. Rouillard F, Josse A, Robin J-R, et al. Cosmetic or Pharmaceutical Compositions Containing Mangiferin or Derivatives Thereof. WO9616632A1; 1996
31. From Nature Co., Ltd. Cosmetic Composition, Beverage or Pharmaceutical Composition for Treating E.G. Xeroderma, Comprises Eruca Sativa Extract, Coffee Extract and/or Mangiferin as Active Ingredient. KR2011132209A; 2011
32. Elc Man Llc. Maes DH, Declercq L, Corstjens HA, et al. Cosmetic Compositions Containing Alpha Glucosidase Inhibitors and Methods of Use. WO2009038875A1; 2009
33. Xu G; Hainan Deze Pharmaceutical Research Co., Ltd. Mangiferin Salt and Method of Preparing the Same and Use Thereof. CN101108869B; 2008
34. Hainan Deze Pharmaceutical Research Co., Ltd. Use of Mangiferin Calcium Salt as Peroxisome Proliferator-Activated Receptor Agonist. CN101461819A; 2009
35. Hainan Deze Drug Res Co., Ltd. Usage of Mangiferin Calcium Salt Taken as AMPK Agonist. CN101919839A; 2010
36. Hainan Deze Drug Res Co., Ltd. Teng H, Wu W. Mangiferin-Berberine Salt, Manufacturing Method and Use Thereof. WO2010145192A1; 2010
37. Guangxi College Traditional Chinese. Mangiferin-berberine composition. CN101066275A; 2007
38. Shanghai Inst Materia Medica. Chinonin Complex, Preparation Method and Application Thereof. CN101756955B; 2010
39. Li X. Mangiferin Derivatives and Its Prepn. Method, and Use as Medicine. CN1757648C; 2006
40. Univ Pla Second Military Medical, Univ Second Military Medical Pla. Function of anemarrhena extract for preparing medicine of treating prostatic hyperplasia. CN101062250A; 2007
41. Fujifilm Corp. Oral Administration Composition Containing Plant Of Genus Salacia. JP2010043035A; 2010
42. Quimica Farmaceutica Centro. Compositions Obtained From Mangifera Indica L. WO2000038699A1; 2000
43. Omoigui OS. Method of Prevention and Treatment of Aging, Age-Related Disorders and/or Age-Related Manifestations Including Atherosclerosis, Peripheral Vascular. WO2006121558A3; 2006
44. Tianjin University of Chinese Medicine and Tianjin University of Traditional Chinese Medicine. Diffractive Ring Mangiferin in Mango Leaf and New Application of Mango Leaf Extract Containing Diffractive Ring Mangiferin. CN101647794B; 2010
45. Tiandong Natural Plant Product. Mangiferin Preparation and Production Thereof. CN1490014C; 2004
46. Hainanshengke Natural Medicine. Medicinal Composition Containing Mangiferin and Its Preparing Method. CN1977855A; 2007
47. Fujifilm Corp. Oral Administration Composition Containing Plant Belonging To Genus Salacia. JP2009215276A; 2009
48. Fujifilm Corp. Oral Administration Composition Containing Plant Belonging To The Genus Salacia. JP2009215275A; 2009
49. Tsumura & Co. Body Temp. Lowering Agent-E.G. Contg. Timosaponin A-Iii, Mangiferin or Linoleic Acid. JP7267864A; 1995
50. Univ Akron. Polymer Composition With Phytochemical and Dialysis Membrane Formed From the Polymer Composition. US20110186518A1; 2011
51. Univ Akron. Kyu T, Chandrasekaran N. Polymer Composition and Dialysis Membrane Formed from the Polymer Composition. WO2010065484A1; 2010
52. Univ Do Porto. Xantonas Sulfatadas E Anä Logos Xantä "Nicos Glicosilados Sulfatados Com Actividade Anticoagulante E Processos Para A Sua PreparaäzA ? f o. PT104739A; 2011
53. Guangxi University of Chinese Medicine. Mangiferin Cream with Anti-Herpes Simplex Virus Effect. CN102512359A; 2012
54. Vichkanova Serafima A, Shipulina Ljudmila D, Glyzin Vladimir I, et al. Medicated Compound for Treating Diseases Infected By Virus of the Herpes Group. US4436732A; 1984
55. Univ Pla 2Nd Military Medical. Application of Mangiferin as Synergist of Antifungal Agents. CN102204909A; 2011
56. Nat Inst Immunology. A Novel Process for Isolation of Mangiferin A Process For Preparing Mangiferin-Containing Formulation Used For Preventing/ Treating Parasite Infections And A Composition Used For The Prevention/Treatment Of Parasitic Diseases. IN183778A1; 2000
57. Institute Of Hygiene Environmental Medicine, Pla Academy of Military Medical Sciences. Application Of Mangiferin In Preparing Anti-Influenza Virus Medicament. CN101461820A; 2009
58. Natreon, Inc. Polyherbal Compositions and Methods For Treating Viral Infections. WO2006078424A3; 2006
59. Interlab Corp. Winter RW, Riscoe MK, Hinrichs DJ, et al. Xanthone Analogs for the Treatment of Infectious Diseases. WO9734482A1; 1997
60. Universidade Federal De Minas Gerais. Composiçäo Farmacêutica Contendo Derivados Acilados De Mangiferina E Uso. BR2010001164A2; 2011
61. Guangxi Traditional Chinese Medical University. Mangiferin Penta-Esterified Derivative. CN102432601A; 2012
62. Guangxi Traditional Chinese Medical University. Mangiferin Hepta-Propyl-Esterified Derivative. CN102432602A; 2012
63. Guangxi Traditional Chinese Medical University. Preparation Method and Pharmacological Effect Of Mangiferin Hexa-Butyl-Esterified Derivative. CN102432603A; 2012
64. Univ Kyung Hee Univ Ind Coop and Whan In Pharmaceutical Co. Composition Comprising an Extract of Anemarrhena Asphodeloides Bunge for Preventing and Treating Arthritic Diseases. WO2009104901A3; 2009
65. Univ Kyunghee Ind Coop. Composition useful for treating arthritic diseases comprises extract of mixed herbs with Lonicera japonica thunb and Anemarrhena asphodeloides bunge. WO2009104913A2; 2009
66. Univ Kinki. Antiphlogistic Agent, And Remedy of Inflammatory Disease in Arthritis. JP2009023935A; 2009
67. Guangxi Traditional Chinese Me. Preparation Method and Application of Water-Soluble Mangiferin Monosodium Salt. CN1919857A; 2007
68. Deng J. Medicine for Treating Acute Bronchitis and Preparation Method Thereof. CN101773492A; 2010
69. Qinghai Pulante Pharmaceutical. Method for Preparing Anti-Hepatitis Active Part from Swertia Main Pharmaceutical Plant. CN1730027A; 2006
70. Univ Nanjing. He B, Wu X, Chu J, et al. Fructosylated Mangiferin and Preparation Method Therefor and Use Thereof. WO2013004086A1; 2013
71. Second Military Medical University Pla. Combination of Anemarrhena Extract and Phellodendron Extract and the Function Thereof. CN101062249B; 2007
72. Univ Taipei Medical. Extracts of Aquilaria Hulls and Use Thereof In the Treatment of Cancer. US2011160152B2; 2011
73. Institute Of Biophysics, Chinese Academy of Sciences. Medicinal Compound Preparation for Preventing and Curing Cerebral Apoplexy and Method for Preparing Same. CN101618092A; 2010
74. Kim D. Pharmaceutical Composition for Treating Memory Loss, for Improving Impairment of Cholinergic Nervous System and for Use As Health Food, Comprises One Or More Compounds Selected From Mangiferin, Neomangiferin Or Timosaponin. KR2009048710B1; 2009
75. Univ Kyunghee Ind Coop. Composition Used In Pharmaceutical Composition Useful For Preventing And/Or Treating Alzheimer'S Disease, Parkinson'S Disease, Pick'S Disease, Huntington'S Disease, And Stroke, Comprises Mangiferin, Neomangiferin And Norathyriol. KR2011106747B1; 2011
76. Univ Del Pais Vasco, Univ Pablo Olavide. Compounds having neuroprotective properties. WO2007077279A1; 2007
77. Garrido G, González D, Lemus Y, et al. Protective effects of a standard extract of Mangifera indica L. (VIMANG) against mouse ear edemas and its inhibition of eicosanoid production in J774 murine macrophage. Phytomedicine 2006;13(6):412-18
78. Roche LD, Pérez AF. Protective effects of Mangifera indica L. Extract against lipofundin-induced oxidative stress in rats. Pharmaceutical Crops 2012;3:94-8
79. Gil del Valle L, Serrano López T, Calderón Fuentes O, et al. Effect of Vimang- in HIV/AIDS patients. Rev Cubana Med Trop 2010;62(3):200-6
80. http://www.salaretin.com/whats.htm
81. Hou S, Wang F, Li Y, et al. Pharmacokinetic study of mangiferin in human plasma after oral administration. Food Chem 2012;132(1):289-94
82. Jain PK, Kharya M, Gajbhiye A. Pharmacological evaluation of mangiferin herbosomes for antioxidant and hepatoprotection potential against ethanol induced hepatic damage. Drug Dev Ind Pharm 2012;doi: 10.3109/ 03639045.2012.738685
83. Niu Y, Li S, Na L, et al. Mangiferin decreases plasma free fatty acids through promoting its catabolism in liver by activation of AMPK. PLoS One 2012;7(1):e30782
84. Leiro J, Arranz JA, Yáñez M. Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. Int Immunopharmacol 2004;4(6):763-78
85. Bhatia HS, Candelario-Jalil E, de Oliveira AC, et al. Mangiferin inhibits cyclooxygenase-2 expression and prostaglandin E2 production in activated rat microglial cells. Arch Biochem Biophys 2008;477(2):253-8
86. Liu YW, Zhu X, Yang QQ, et al. Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-Associated cognitive decline in rats. Psychopharmacology (Berl) 2013;228(4):585-94
87. Shoji K, Tsubaki M, Yamazoe Y, et al. Mangiferin induces apoptosis by suppressing Bcl-xL and XIAP expressions and nuclear entry of NF-kB in HL-60 cells. Arch Pharm Res 2011;34(3):469-75
88. Ahmad A, Banerjee S, Wang Z, et al. Aging and Inflammation: Etiological culprits of Cancer. Curr Aging Sci 2009;2(3):174-86
89. Wang Q, Deng J, Yang K, et al. Effects of mangiferin on cytokines in rats with chronic bronchitis and expression of macrophage COX-2 in mice. Zhongguo Zhong Yao Za Zhi 2011;36(10):1348-52